Backed — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Cytosolix, Inc.Jun 2023
Acidity-targeting therapeutics for solid tumours.
Tolland, US
Board seatAlex Brunicki· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.